AASPN

Today 2019.10.19
END

Sponsorship
& Exhibition

Directory of Sponsors & Exhibitors

home  >  Sponsorship & Exhibition  >  Directory of Sponsors & Exhibitors
When you need us most, our clinically differentiated surgical care products support hemostasis, tissue sealing, reconstruction, tissue repair, intraoperative patient care and inhaled anesthesia.

Our robust portfolio has been demonstrated to reduce intra- and post-operative complications, including complications that require costly blood transfusions and extend operating time.
Less complications often translates into faster recovery for your patients and greater cost efficiencies for your hospital or clinic.
Bukwang Pharmaceuticals Co., Ltd. is an R&D-focused pharma company based in Seoul, Korea. Founded in 1960, Bukwang has well-rounded experience in development of new drugs, coming from the development of a novel hepatitis B drug, Levovir (clevudine). This experience spans from early- to late-stage development, multinational clinical trials, interaction with overseas regulatory bodies and global co-operation with partners under license agreement. Bukwang has engaged in diverse business models, including license-in/-out, co-development, acquisition and direct investment.

Bukwang is looking for drug candidates for innovative treatments for diseases with unmet medical needs. Currently, Bukwang’s pipeline of development comprises a novel anti-diabetes candidate, two candidates for movement disorders in Parkinson’s disease, and an anti-cancer candidate, all licensed in from respective overseas partners.
ChoDang has been producing about 60 excellent products

Starting with Duribang®, a peripheral blood circulation improvement medicine in OTC field, and Mesocan®, the anti-atherogenic agent in ETC field, ChoDang has been producing about 60 excellent products, and continuously investing in R&D

Because ChoDang is affiliated with BaekJe Pharm., the largest Distributor of pharmaceutical products in Korea, our sales network is strong and well organized. Also, We are proud to say that we are doing our parts in returning the benefits back to our society by supporting the educational system through BaekJe High School and ChoDang University, and helping people in Desperate needs through ChoEun Welfare Foundation

ChoDang Pharmaceutical Co., LTD has always been making effort to develop new medicines and trying to introduce new technology by joining partnership with well-known pharmaceutical companies around the world. We are also fully participating with many research facilities in developing new materials.

Our company is fully equipped with advanced facilities and high-tech manufacturing-line and we are making every effort to produce high-quality products and to preserve remedial effect of medicines. We promise that we will always do our best to improve not only the quality of our products, but also the quality of our lives.

For the last, I would like to thank again for your continuous support for ChoDang Pham. and wish everyone a healthy and happy life.
Daewoong based in Seoul, Korea is a total healthcare group founded on 1945.

And DaewoongBio Inc, was established in 1983 as an independent subsidiary of Daewoong Group.

Daewoong Bio is the No.1 API and finished pharmaceutical product company in Korea and possesses world-class cutting-edge production facilities and technology.

Since its establishment, Daewoong Bio has been continuously developing its facilities and R & D to produce the world's best quality products We are doing our best to supply only.



















1945 stablished as Daehan hemical Industry Co. Ltd

1961 Launched URSA (Ursodeoxycholic Acid)

1978 Changed Corporate Name to Daewoong Pharmaceutical Co.Ltd

1983 Established Daewoong Chemical Co.Ltd (Now Daewoong Bio. Inc)

2014 Established Daewoong Liaoning R&D Institute in China

2015 Established 1st Biopharmaceutical Manufacturing plant in Indonesia
- Acquired HANALL BIOPHARMA Co. Ltd

2017 Established overseas corporation in Japan Biosimilar ‘Epodion’ approved by Indonesia BPOM Became shareholder of Trapharco of Vietnam
DePuy Synthes Power Tools offers a comprehensive range of air, electric, and battery driven high and low speed instrument systems, reamers, and saws to meet the clinical needs for orthopaedics, traumatology, neurosurgery, neurotology, spinal procedures, otolaryngology, and cranio-facial surgery.

Depending on preferences and the type of surgery performed, both modular and dedicated power systems are available.

Our instruments provide consistent power and smooth performance for even the most demanding applications, assuring high-performance and reliability.







Dong-A ST operates ETC drug, overseas, and medical equipment & diagnostics businesses.

As the R&D hub of Dong-A Socio Group, Dong-A ST puts considerable efforts on developing global new drugs, supported by a top-level research infrastructure which includes cutting-edge research centers and highly-skilled research experts.

Dongbang Healthcare Co., Ltd. was established in 1979 and has been providing best medical devices and supplies to hospitals. Currently, we are providing medical products for Neurosurgery, General Surgery, Anesthesiology, ENT, Ophthalmology, General patient care, and Emergency medicine.

Dongbang Healthcare is representing Integra’s Heyer-Schulte Neuro-Shunting Systems and CUSA - Ultrasonic Surgical System in Korea.

Dongsan Hearing., Ltd is sole distributor of LivaNova PLC, which is manufacturer of VNS (Vagus Nerve Stimulation). VNS Therapy® System – the number 1 implantable device for drug-resistant epilepsy.

As pioneers of the VNS Therapy® System, we continue to advance medical device solutions for people affected by drug-resistant epilepsy and treatment-resistant depression.

Our Mission is to provide high quality medical device and service to drug-resistant epilepsy to reduce seizures and increase quality of life.
Since its beginnings in 1945, the KARL STORZ family company has grown into a global manufacturer and distributor of endoscopes, medical instruments, and devices.

Our range of endoscopic instruments for human medicine, veterinary medicine, and industrial endoscopy now includes more than 15,000 products.

The most recent KARL STORZ developments are in digital documentation systems and comprehensive operating room concepts.

As a system supplier, the company combines its expertise in endoscopy with software solutions to achieve integration in the operating room and to support clinical process and resource management.

Medtronic plc, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world.

Medtronic employs more than 86,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries.

The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Neuroplus Inc. was established in 2010. We are a National Distributor to the Korean Surgical and Medical market. Our CEO, Youngsoo Park, has relationships with the many professors and doctors in South Korea, especially in the University Hospitals’ Neurology, Neurosurgery and Cardiovascular departments.

Our management team has over 15 years of experience in marketing and selling neurological, neurosurgical and cardiovascular equipment. Our selling products are highly recognized by our buyers.

We are devoted to supplying Korean Hospital clients with innovative and unique products to enhance the clinician’s ability to provide the best patient care available at reasonable costs.

Orthokorea is a company specialized in CRO (Cranial Remodeling Orthosis) which imports and sells STARband, a product of Orthomerica (U.S.A), since 2007.

The Orthomerica’s STARband is a custom-designed medical helmet or headband for treating babies with deformational plagiocephaly (flat head syndrome) and other abnormal, crooked or flattened head shapes.

The STARband plagiocephaly helmet was cleared by the US FDA in 2001 and is the most prescribed plagiocephaly treatment device—successfully helping over 350,000 babies worldwide!

Back to Top